Pienta Kenneth

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pienta Kenneth's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
263.45
Quantity 69,579 -37.7%
Value US$273,865
Transaction date
Planned sale
Price
296.28
Quantity 94,635 +29.5%
Value US$4,760,388
Transaction date
Planned sale
Price
230.13
Quantity 20,756 -41.8%
Value US$3,586,366
Transaction date
Planned sale
Price
15.15
Quantity 16,000 -88.9%
Value US$242,422
Transaction date
Purchase
Price
15.07
Quantity 2,720 +136.0%
Value US$40,980
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-17 2021-03-16
PlS Planned sale
69,579 -37.7%
263.45
US$273,865 		69,579 -37.7% 263.45 US$273,865
2021-03-17 2021-03-15
PlS Planned sale
94,635 +29.5%
296.28
US$4,760,388 		94,635 +29.5% 296.28 US$4,760,388
2021-02-18 2021-02-17
PlS Planned sale
20,756 -41.8%
230.13
US$3,586,366 		20,756 -41.8% 230.13 US$3,586,366
2021-02-18 2021-02-16
PlS Planned sale
16,000 -88.9%
15.15
US$242,422 		16,000 -88.9% 15.15 US$242,422
2021-01-22 2021-01-20
B Purchase
2,720 +136.0%
15.07
US$40,980 		2,720 +136.0% 15.07 US$40,980